NantHealth (NH) Stock Price, News & Analysis

Company Overview

NantHealth, Inc. engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management. The company was founded by Patrick Soon-Shiong on July 7, 2010 and is headquartered in Morrisville, NC.

Key Stats

• Today's Range: $0.0110 to $0.0110
• 50-Day Range: $0.00 to $0.05
• 52-Week Range: $1.24 to $9.75
• Volume: N/A
• Average Volume: 38,073 shs
• Market Capitalization: $84.73 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NH Stock Analysis - Frequently Asked Questions

How have NH shares performed this year?

NantHealth's stock was trading at $0.0031 at the beginning of 2025. Since then, NH stock has increased by 254.8% and is now trading at $0.0110.
View the best growth stocks for 2025 here.

How were NantHealth's earnings last quarter?

NantHealth, Inc. (NASDAQ:NH) announced its earnings results on Thursday, November, 4th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.08) by $0.02. The company earned $14.36 million during the quarter, compared to analysts' expectations of $17.70 million.

When did NantHealth IPO?

NantHealth (NH) raised $91 million in an IPO on Thursday, June 2nd 2016. The company issued 6,500,000 shares at a price of $12.50-$15.50 per share. Jefferies and Cowen and Company acted as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

How do I buy shares of NantHealth?

Shares of NH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of NantHealth own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NantHealth investors own include NVIDIA (NVDA), Sorrento Therapeutics (SRNE), AT&T (T), Verizon Communications (VZ), AbbVie (ABBV), Gilead Sciences (GILD).

Company Calendar

• Last Earnings: 11/04/2021
• Today: 7/02/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Data processing & preparation
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:NH
• Previous Symbol: NYSE:NH
• CIK: 1566469
• Web: www.nanthealth.com
• Phone: (855) 949-6268
• Fax: N/A
• Employees: 340
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($7.65)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$67.78 million
• Net Margins: -94.67%
• Pretax Margin: -95.06%
• Return on Equity: N/A
• Return on Assets: -39.82%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.64
• Quick Ratio: 0.64

Sales & Book Value

• Annual Sales: $67.68 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($30.72) per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 7,703,000
• Free Float: 2,981,000
• Market Cap: $84.73 thousand
• Optionable: Not Optionable
• Beta: 1.82